Investment

CVS voluntarily pulling decongestants from shelves that contain ineffective ingredient

1 Mins read

CVS Health Corp.
CVS,
-1.47%
is pulling decongestants off their shelves that contain an ingredient an Food and Drug Administration advisory committee determined did not work, according to a Thursday report from the Wall Street Journal. Used as a key ingredient in decongestants for nearly a century, FDA advisors in September determined that phenylephrine did not improve congestion. While the FDA has not made a decision on the ingredient, CVS said it is voluntarily taking products containing it off their shelves. CVS shares were last up 0.1% in recent activity.

Read the full article here

Related posts
Investment

Trump’s tariffs, whether implemented or not, have already hurt the U.S. auto industry

1 Mins read
Last Updated: March 3, 2025 at 4:40 p.m. ETFirst Published: March 3, 2025 at 10:33 a.m. ET U.S. carmakers and auto-parts suppliers, including many…
Investment

Chipotle praised for ‘quality and size’ as it faces a ‘choppier’ consumer

1 Mins read
Published: March 3, 2025 at 10:57 a.m. ET Chipotle Mexican Grill Inc.’s stock rose Monday after the restaurant chain picked up a fresh…
Investment

What Nvidia’s market valuation says about where the stock will be in 5 years

1 Mins read
Last Updated: March 3, 2025 at 4:23 p.m. ETFirst Published: March 3, 2025 at 8:05 a.m. ET Nvidia Corp.’s market performance over the past…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *